| Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy KR Crews, AA Monte, R Huddart, KE Caudle, ED Kharasch, A Gaedigk, ... Clinical Pharmacology & Therapeutics 110 (4), 888-896, 2021 | 278 | 2021 |
| Assessment of healthcare professionals’ knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt M Nagy, M Lynch, S Kamal, S Mohamed, A Hadad, S Abouelnaga, ... Personalized Medicine 17 (4), 251-260, 2020 | 35 | 2020 |
| Evaluating the current level of pharmacists’ pharmacogenomics knowledge and its impact on pharmacogenomics implementation M Nagy, E Eirini Tsermpini, S Siamoglou, GP Patrinos Pharmacogenomics 21 (16), 1179-1189, 2020 | 15 | 2020 |
| Determination of voriconazole and co-administered drugs in plasma of pediatric cancer patients using UPLC-MS/MS: A key step towards personalized therapeutics MA Al-Ghobashy, SM Kamal, GM El-Sayed, AK Attia, M Nagy, A ElZeiny, ... Journal of Chromatography B 1092, 489-498, 2018 | 10 | 2018 |
| Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies M Nagy, M Attya, GP Patrinos Pharmacogenomics 21 (17), 1247-1264, 2020 | 8 | 2020 |
| Management of chronic myeloid leukaemia: current treatment options, challenges, and future strategies S Younes, MA Ismail, R Al-Jurf, A Ziyada, GK Nasrallah, PV Abdulrouf, ... Hematology 28 (1), 2196866, 2023 | 4 | 2023 |
| Healthcare workers’ mental health and perception towards vaccination during COVID-19 pandemic in a Pediatric Cancer Hospital M Alalawi, M Makhlouf, O Hassanain, AA Abdelgawad, M Nagy Scientific Reports 13 (1), 329, 2023 | 4 | 2023 |
| A Comparison between Three Different Automated Total 25-hydroxyvitamin D Immunoassay Methods and Ultra Performance Liquid Chromatography H Reda, S Soliman, H Girguis, M Nagy, Y Mahmoud, N Yasser Asian Pacific Journal of Cancer Prevention: APJCP 21 (4), 1039, 2020 | 3 | 2020 |
| Late-onset toxicities of monoclonal antibodies in cancer patients M Alalawi, AS Bakr, R Reda, KT Sadak, M Nagy Immunotherapy 14 (13), 1067-1083, 2022 | 2 | 2022 |
| Knowledge, attitudes and practices of Egyptian healthcare professionals toward therapeutic drug monitoring service as a principal component of personalized medicine S Hassan, O Hassanain, S Kamal, L Shalaby, M Nagy Personalized Medicine 19 (6), 509-521, 2022 | 1 | 2022 |
| Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine … AA Aziz, S Rogers, O Hassanien, L Shalaby, M Nagy Personalized Medicine 19 (6), 495-507, 2022 | 1 | 2022 |
| Safety Pharmacology in the Era of Precision Medicine MN Zeina N Al-Mahayri Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays, p1-16, 2024 | | 2024 |
| THE ROLE OF CLINICAL PHARMACIST IN PARENTERAL NUTRITION FOR PEDIATRIC CANCER PATIENTS IN 57357 CHILDREN CANCER HOSPITAL EGYPT (CCHE) N Ezzat, A Wagdy, M Abdelmonem, Z Badr, A Emad, A El-Zeiny, M Nagy, ... PEDIATRIC BLOOD & CANCER 69, S346-S346, 2022 | | 2022 |
| Abstract LB-B19: Investigating the effect of pharmacogenetic variations on voriconazole levels in pediatric cancer patients D Saeed, L Shalaby, M Nagy, A ElZeiny, TM Mostafa, MT ElRakaiby, ... Molecular Cancer Therapeutics 18 (12_Supplement), LB-B19-LB-B19, 2019 | | 2019 |
| TIO13. An intensive clinical pharmacogenomics course for pharmacists in developing countries: the University of Colorado and Children's Cancer Hospital Egypt experience SA Christina Aquilante,Sherif kamal ,Mohamed Nagy,Jodie Malhotra,Kari ... Monash Pharmacy Education Symposium 2017 17 (1), 238 - 307, 2017 | | 2017 |
| MTHFR C677T, PT G20120A and FV Leiden as Risk Factors for Thrombosis in Egyptian Pediatric ALL Patients MN Ahmed | | 2015 |
George P. PatrinosUniversity of Patras, Department of PharmacyVerified email at upatras.gr
